Why the study?
Does detectable serum cardiac troponin T predict increased mortality risk in patients with chronic precapillary pulmonary hypertension?
Does detectable serum cardiac troponin T predict increased mortality risk in patients with chronic precapillary pulmonary hypertension?
Detectable serum cardiac troponin T serves as an independent prognostic marker for increased mortality in patients with chronic precapillary pulmonary hypertension.
May support cTnT for risk stratification in precapillary PH; leaves open whether troponin-guided therapy improves survival.
Detectable cTnT is a so-far ignored independent marker of increased mortality risk in patients with chronic precapillary PH, supporting the role of progressive myocyte injury in the vicious circle leading to hemodynamic destabilization.
No takes yet. Share an insight, caveat, or question.
Torbicki et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: